SCHEMBL5773754

SCHEMBL5773754

Clc1ccc(Cl)c(N2CCN(CCCc3[nH]nc4c3CCCC4)CC2)c1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADRA1B P35368 11/20 0.49
HTR1A P08908 9/20 0.49
ADRA1A P35348 4/20 0.46
ADRA1D P25100 1/20 0.43
ALDH1A1 P00352 2/20 0.40
CYP3A4 P08684 1/20 0.40
CHRM1 P11229 1/20 0.40
DRD3 P35462 1/20 0.40
OPRK1 P41145 1/20 0.40
PDE4D Q08499 1/20 0.40
KCNH2 Q12809 1/20 0.40
PDE3A Q14432 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
RPS6KB1 P23443 1/20 0.38
MEN1 O00255 1/20 0.38
MAPK1 P28482 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MCOLN3 Q8TDD5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5773463 0.88 KDM4E (0.49) ADRA1BHTR1AADRA1AADRA1DDRD3
SCHEMBL5772229 0.84 SIGMAR1 (0.52) HTR1ADRD3
SCHEMBL5774841 0.84 HTR7 (0.42) HTR1ADRD3
SCHEMBL5776696 0.84 SIGMAR1 (0.51) HTR1ADRD3
SCHEMBL5776645 0.83 KCNH2 (0.57) HTR1AADRA1ACHRM1DRD3KCNH2
SCHEMBL5775854 0.83 DRD2 (0.54) HTR1AADRA1ADRD3
Hydrochloric Acid SCHEMBL5770744 0.81 SIGMAR1 (0.51) HTR1ADRD3
SCHEMBL5777128 0.80 DRD2 (0.53) HTR1AADRA1ADRD3
SCHEMBL5772576 0.78 HTR1A (0.48) HTR1ADRD3
SCHEMBL5772832 0.78 SIGMAR1 (0.53) HTR1ADRD3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885883-B1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF MITSUBISHI PHARMA CORP (JP) 2006-11-02 EP disclosed
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed